Company genOway SA Xetra
Equities
JEH
FR0004053510
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
2023 | GENOWAY : Euroland initiates buy coverage | CF |
Business Summary
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Genetically Modified Mouse, Rat and Cell Line Models
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Founder | - | 28/02/99 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 30/09/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 28/02/99 | |
Raffy Kazandjian
BRD | Director/Board Member | - | - |
Patrick Blain
BRD | Director/Board Member | 72 | - |
Director/Board Member | - | - | |
Chief Executive Officer | - | - | |
Andre Tartar
BRD | Director/Board Member | - | - |
Director/Board Member | 59 | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,046,590 | 6,566,389 ( 72.58 %) | 247,882 ( 2.740 %) | 72.58 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+35.14% | 51.51B | |
-7.43% | 39.03B | |
+35.88% | 38.91B | |
-10.62% | 26.68B | |
+11.63% | 26.13B | |
-17.77% | 19.91B | |
+40.52% | 13.71B | |
+30.70% | 12.38B | |
-3.41% | 11.74B |
- Stock Market
- Equities
- ALGEN Stock
- JEH Stock
- Company genOway SA